Virus Therapy
Viral Replicon Particles for Head and Neck Cancer
Recruiting1 awardPhase 1
Stanford, California
This trial aims to test the safety of injecting a virus replicon particle containing saRNA encoding IL-12 directly into head and neck cancer tumors. They want to see how the tumors respond to this treatment
Gene Therapy
Gene Therapy for Cancer Recurrence
Recruiting1 awardPhase 2
Redwood City, California
This trial aims to determine if a certain treatment can increase a specific protein expression in the skin of patients with a certain skin condition after removing a type of skin cancer. The goal is to reduce the risk
Remdesivir + SOC for Coronavirus
Recruiting1 awardPhase 3
San Francisco, California
This study looks at the safety and effectiveness of Remdesivir in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure. Participants in the study will be treated with Remdesivir plus current standard of care (SOC), or with placebo plus current SOC.
Popular Filters
Phase 3 Trials
Corticosteroid
Baxdrostat + Dapagliflozin for Chronic Kidney Disease and High Blood Pressure
Recruiting1 awardPhase 3
Fremont, California
This trial will test a new medication called Baxdrostat with Dapagliflozin to see if it can improve kidney health and reduce the risk of heart problems in people with chronic kidney
Peripheral Nerve Stimulation for Neuropathic Pain
Recruiting2 awardsPhase 3
Palo Alto, California
This trial is studying 134 patients with chronic nerve pain in the legs. They will be split into two groups - one receiving standard medical treatment and the other receiving both standard treatment and peripheral nerve stimulation therapy
Aviptidil + SOC for Coronavirus
Recruiting1 awardPhase 3
San Francisco, California
This study looks at the safety and effectiveness of Aviptidil in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure. Participants in the study will be treated with Aviptidil plus current standard of care (SOC), or with placebo plus current SOC.
Trials With No Placebo
Peripheral Nerve Stimulation for Neuropathic Pain
Recruiting2 awardsPhase 3
Palo Alto, California
This trial is studying 134 patients with chronic nerve pain in the legs. They will be split into two groups - one receiving standard medical treatment and the other receiving both standard treatment and peripheral nerve stimulation therapy
NMDA Receptor Antagonist
Ketamine for Anorexia
Recruiting1 awardPhase 2
San Francisco, California
This trial is testing the effects of a single dose of IV ketamine on adolescents and young adults with anorexia nervosa. The researchers believe that ketamine may help improve cognitive flexibility and make hospital
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.